CorMatrix secures FDA IDE nod to conduct trial of Cor TRICUSPID ECM valve for pediatric and adult patients
CorMatrix Cardiovascular has announced FDA approval of an early feasibility study IDE to evaluate the safety and feasibility…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
25 Jan 19
CorMatrix Cardiovascular has announced FDA approval of an early feasibility study IDE to evaluate the safety and feasibility…
24 Jan 19
Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, and Talis Clinical, a leading provider of healthcare…
24 Jan 19
Royal Philips and the American Heart Association have announced a collaboration to increase sudden cardiac arrest (SCA) survival…
23 Jan 19
Boston Scientific has announced positive 12-month data demonstrating that patients who were treated with the VICI VENOUS STENT…
22 Jan 19
Helathcare firm Abbott has secured approval from the US Food and Drug Administration (FDA) for its TactiCath contact…
21 Jan 19
Interventional vascular solutions provider VentureMed Group has started enrollment in Switzerland in the study named BEnefit of arterial…
18 Jan 19
LivaNova stated that its sutureless aortic valve Perceval has shown positive results in three studies for treating aortic…
18 Jan 19
HighLife SAS, a medtech company focused on the development of a unique transcatheter mitral valve replacement (TMVR) system…
17 Jan 19
Cardiovascular Systems (CSI), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral…
17 Jan 19
Healthcare firm Abbott has exercised its option to acquire medical device firm Cephea Valve Technologies for an undisclosed…